Radiotherapy as a risk factor for malignant melanoma after childhood skin hemangioma.

Abstract

The aim of this study was to determine therapy-related risk factors for the development of melanoma after hemangioma. A cohort study was conducted among 4620 patients treated before 16 years of age for skin hemangioma in France. A nested case-control study was also conducted on 13 patients who developed a melanoma (cases) matched with five controls in cohort according to sex, age at the hemangioma diagnostic, the calendar year of occurrence of the hemangioma, and follow-up. The radiation dose received at the site of the melanoma and at the same site in controls was estimated, and named 'local dose'. A total of 13 melanomas were registered during an average follow-up of overall 35 years, the risk of developing melanoma after a hemangioma treatment was 2.5-fold higher [95% confidence interval (CI): 1.4-4.1] compared with that of the general population, this ratio being only 0.8 (95% CI: 0.05-3.6) in 896 patients who did not receive radiotherapy, but 3.0 (95% CI: 1.6-5.1) after radiotherapy. When adjusting on sex, age, and year of the treatment and follow-up duration, melanoma risk was 11.9 (95% CI: 1.4-123) times higher in patients treated with ytrium 90 than in the ones who did not received radiotherapy. In the case-control study, the risk of melanoma was not linked to the local radiation dose. Indeed, the increase in melanoma risk was observed even for very low local doses. Compared with the corresponding skin areas in patients who did not receive radiotherapy, the ones having received less than 0.001 Gy had a melanoma risk of 3.9 (95% CI: 0.5-32) and those who received more than 0.01 Gy had a risk of 6.9 (0.5-99). This study suggests that radiation therapy of skin hemangioma increases the risk of further melanoma, but we were not able to evidence a relation with the local dose. Nevertheless, childhood treated for hemangioma should be considered at risk for developing melanoma and suspicious pigmented lesions should be carefully evaluated even far from treated areas.

• Authors: Nadia Haddy, Abdeddahir Mousannif, Catherine Paoletti, Marie-Gabrielle Dondon, Akhtar Shamsaldin, Françoise Doyon, Marie-Françoise Avril, Philippe Fragu, Martine Labbé, Dimitry Lefkopoulos, Jean Chavaudra, Caroline Robert, Ibrahima Diallo, Florent de Vathaire
• Journal: Melanoma research (Melanoma Res) Vol. 22 Issue 1 Pg. 77-85 (Feb 2012) ISSN: 1473-5636 [Electronic] England
• PMID: 22082956 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Adolescent
• Case-Control Studies
• Child
• Child, Preschool
• Cohort Studies
• Female
• Hemangioma (complications, radiotherapy)
• Humans
• Infant
• Male
• Melanoma (etiology)
• Radiation Injuries (etiology)
• Radiotherapy (adverse effects)
• Risk Factors
• Skin Neoplasms (complications, etiology, radiotherapy)